New page: left|200px <!-- The line below this paragraph, containing "STRUCTURE_2rk1", creates the "Structure Box" on the page. You may change the PDB parameter (which sets the PD...
'''DHFR R67 Complexed with NADP and dihydrofolate'''
===DHFR R67 Complexed with NADP and dihydrofolate===
==Overview==
<!--
Type II dihydrofolate reductase (DHFR) is a plasmid-encoded enzyme that confers resistance to bacterial DHFR-targeted antifolate drugs. It forms a symmetric homotetramer with a central pore which functions as the active site. Its unusual structure, which results in a promiscuous binding surface that accommodates either the dihydrofolate (DHF) substrate or the NADPH cofactor, has constituted a significant limitation to efforts to understand its substrate specificity and reaction mechanism. We describe here the first structure of a ternary R67 DHFR.DHF.NADP+ catalytic complex, resolved to 1.26 A. This structure provides the first clear picture of how this enzyme, which lacks the active site carboxyl residue that is ubiquitous in Type I DHFRs, is able to function. In the catalytic complex, the polar backbone atoms of two symmetry-related I68 residues provide recognition motifs that interact with the carboxamide on the nicotinamide ring, and the N3-O4 amide function on the pteridine ring. This set of interactions orients the aromatic rings of substrate and cofactor in a relative endo geometry in which the reactive centers are held in close proximity. Additionally, a central, hydrogen-bonded network consisting of two pairs of Y69-Q67-Q67'-Y69' residues provides an unusually tight interface, which appears to serve as a "molecular clamp" holding the substrates in place in an orientation conducive to hydride transfer. In addition to providing the first clear insight regarding how this extremely unusual enzyme is able to function, the structure of the ternary complex provides general insights into how a mutationally challenged enzyme, i.e., an enzyme whose evolution is restricted to four-residues-at-a-time active site mutations, overcomes this fundamental limitation.
The line below this paragraph, {{ABSTRACT_PUBMED_18052202}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 18052202 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_18052202}}
==About this Structure==
==About this Structure==
Line 34:
Line 38:
[[Category: Plasmid]]
[[Category: Plasmid]]
[[Category: Trimethoprim resistance]]
[[Category: Trimethoprim resistance]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jun 4 09:52:41 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 15:08:06 2008''
Revision as of 15:08, 28 July 2008
This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.
Crystal structure of a type II dihydrofolate reductase catalytic ternary complex., Krahn JM, Jackson MR, DeRose EF, Howell EE, London RE, Biochemistry. 2007 Dec 25;46(51):14878-88. Epub 2007 Dec 4. PMID:18052202
